Jahangier Z N, van der Zant F M, Jacobs J W G, Riedstra H G, Gommans G M M, Verzijlbergen J F, Bijlsma J W J, van Isselt J W
Department of Rheumatology and Clinical Immunology F02.127, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands.
Ann Rheum Dis. 2007 Aug;66(8):1110-2. doi: 10.1136/ard.2005.047373. Epub 2007 Jan 12.
To assess the impact of the intra-articular distribution of (90)yttrium-citrate ((90)Y) on the clinical effect of radiosynoviorthesis (RSO) of the knee and on (90)Y leakage from this joint.
Patients with arthritis of the knee received 185 MBq (90)Y combined with a glucocorticoid, followed by clinical bed rest. Intra-articular (90)Y distribution, measured with a dual-head gamma camera immediately or after 24 hours, was scored as mainly diffuse or mainly focal. Leakage to regional lymph nodes, the liver and spleen was assessed with a dual-head gamma camera after 24 hours. Clinical effect was scored after 6 months by a composite change index (CCI), range 0-12; responders were defined as having a CCI > or =6.
Seventy-eight knees of 69 patients, mostly suffering from undifferentiated arthritis (42%) or RA (28%), were treated. (90)Y distribution was mainly diffuse in 54% and mainly focal in 46% with clinical response rates of 40% versus 56%, respectively, p = 0.3. CCI was not correlated with distribution. (90)Y leakage was found only to the liver and the spleen (mean leakage 0.4% and 1.1%, respectively). Leakage was significantly less in case of diffuse intra-articular (90)Y distribution, whereas leakage to the liver was correlated with distribution (r = 0.68, p<0.001). (90)Y leakage was not correlated with CCI.
Intra-articular (90)Y distribution does not influence the clinical effect of RSO of the knee. Although (90)Y leakage from the joint is less if (90)Y distributes diffusely in the joint cavity, leakage does not seem to hamper the clinical effect.
评估枸橼酸钇(90Y)关节内分布对膝关节放射性滑膜切除(RSO)临床效果及该关节90Y渗漏的影响。
膝关节关节炎患者接受185MBq的90Y联合糖皮质激素治疗,随后卧床休息。用双头γ相机在即刻或24小时后测量关节内90Y分布,分为主要为弥漫性或主要为局灶性。24小时后用双头γ相机评估区域淋巴结、肝脏和脾脏的渗漏情况。6个月后通过综合变化指数(CCI)对临床效果进行评分,范围为0至12;反应者定义为CCI≥6。
69例患者的78个膝关节接受了治疗,大多数患者患有未分化关节炎(42%)或类风湿关节炎(28%)。90Y分布主要为弥漫性的占54%,主要为局灶性的占46%,临床有效率分别为40%和56%,p = 0.3。CCI与分布无关。仅发现90Y渗漏至肝脏和脾脏(平均渗漏分别为0.4%和1.1%)。关节内90Y弥漫性分布时渗漏明显较少,而肝脏的渗漏与分布相关(r = 0.68,p<0.001)。90Y渗漏与CCI无关。
关节内90Y分布不影响膝关节RSO的临床效果。尽管90Y在关节腔内弥漫分布时从关节的渗漏较少,但渗漏似乎并未妨碍临床效果。